Baron Wealth Management LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,845 shares of the healthcare conglomerate’s stock after selling 78 shares during the period. Baron Wealth Management LLC’s holdings in UnitedHealth Group were worth $933,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also bought and sold shares of the company. Strategic Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 3.1% during the 4th quarter. Strategic Planning Group LLC now owns 10,215 shares of the healthcare conglomerate’s stock valued at $5,168,000 after buying an additional 304 shares during the period. Gries Financial LLC boosted its position in shares of UnitedHealth Group by 10.6% in the fourth quarter. Gries Financial LLC now owns 1,791 shares of the healthcare conglomerate’s stock worth $906,000 after purchasing an additional 172 shares during the period. Hanson & Doremus Investment Management grew its position in shares of UnitedHealth Group by 112.9% during the fourth quarter. Hanson & Doremus Investment Management now owns 892 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 473 shares in the last quarter. Invesco LLC lifted its stake in UnitedHealth Group by 7.3% in the 4th quarter. Invesco LLC now owns 1,997 shares of the healthcare conglomerate’s stock worth $1,010,000 after purchasing an additional 136 shares in the last quarter. Finally, Allen Capital Group LLC grew its holdings in shares of UnitedHealth Group by 5.0% in the fourth quarter. Allen Capital Group LLC now owns 10,852 shares of the healthcare conglomerate’s stock valued at $5,490,000 after purchasing an additional 515 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Morgan Stanley cut their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $629.32.
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.
UnitedHealth Group Stock Down 0.8 %
UNH opened at $538.29 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $495.38 billion, a price-to-earnings ratio of 34.73, a PEG ratio of 1.41 and a beta of 0.62. The company has a fifty day moving average of $539.43 and a two-hundred day moving average of $565.28.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.56%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- How Investors Can Find the Best Cheap Dividend Stocks
- Arista Networks’ Stock Plunge: Buying Opportunity for Investors?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- As China Tightens Rare Earth Exports, These 3 Stocks Are in Focus
- What is the NASDAQ Stock Exchange?
- Rebuilding the Empire: Can Dollar General Rally in 2025?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.